Castillon, Jorenda S.

HRN: 23-11-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/27/2023
06/02/2023
IV
750mg
OD
Pneumonia
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: